作者
Multiple Sclerosis Therapy Consensus Group (MSTCG), H Wiendl, KV Toyka, P Rieckmann, R Gold, H-P Hartung, R Hohlfeld
发表日期
2008/10
期刊
Journal of neurology
卷号
255
页码范围
1449-1463
出版商
D. Steinkopff-Verlag
简介
Abstract
This review updates and extends earlier Consensus Reports related to current basic and escalating immunomodulatory treatments in multiple sclerosis (MS). The recent literature has been extracted for new evidence from randomized controlled trials, open treatment studies and reported expert opinion, both in original articles and reviews, and evaluates indications and safety issues based on published data. After data extraction from published full length publications and critically weighing the evidence and potential impact of the data, the review has been drafted and circulated within the National MS Societies and the European MS Platform to reach consensus within a very large group of European experts, combining evidence-based criteria and expert opinion where evidence is still incomplete. The review also outlines a few areas of controversy and delineates the need for future research.
引用总数
学术搜索中的文章
Multiple Sclerosis Therapy Consensus Group (MSTCG)… - Journal of neurology, 2008